Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of flavopiridol in treating
patients with B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma. Drugs used
in chemotherapy, such as alvocidib, work in different ways to stop the growth of cancer
cells, either by killing the cells or by stopping them from dividing.